English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 109951/140887 (78%)
Visitors : 46279688      Online Users : 1264
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/69616


    Title: 藥劑個體生體相等與藥劑互用安全之研究
    Other Titles: Individual Bioequivalence and Drug Interchangeability.
    Authors: 林慧
    Contributors: 統計學系
    Keywords: 處方性;互換性;生體可用率;生體相等性;藥物互換性
    Prescribility;Swichability;Bioavailability;Bioequivalence;Drug interchangeability
    Date: 1995
    Issue Date: 2014-09-02 17:31:57 (UTC+8)
    Abstract: 藥劑可用(Bioavailability)和藥劑生體相等(Bioequivalence)的研究,在今日製藥界成為極重要之課題,美國食品藥物管理局(Food and Drug Administration,FDA)在準則中指出,藥物間相等性的評估應使用平均生體可用性(Average bioavailability)。然而,藥物的互換性(Interchangeability)包括處方性(Prescribility)及交換性(Switchability)。而後者並無法經由平均生體相等來評估。於是個體生體相等學說(Individual bioequivalence)有日漸取代平均生體相等學說的趨勢。本計畫探討了Anderson and Hauck(1990)所提出評估個體生體相等方法的統計特性,並加入母數分配假設以改進其缺失。本計畫亦比較其與Schuirmann(1987)所提出以評估平均相等方法之表現(Performance)。個體生體相等及平均生體相等界限之關係亦在本計畫中有深入之探討。
    The bioavailability and bioequivalence studies between drug products has become an important subject in drug development. The mean bioavailability of the test (T) and the Reference (R) products is currently specified in the FDA guidelines to be used for assessing the bioequivalence of the drug products. However, it has been recognized that the safety for the substitution of a reference drug product with a test drug product in patients, whose concentration may have been titrated to a steady efficacious, and safe level, could be a concern. Therefore, it is suggested that individual bioequivalence be assessed by comparing the distributions of the two drug products within each subject to assure the drug swichability. This paper compares the performance of the individual bioequivalence and average bioequivalence by using the procedures proposed by Anderson and Hauck (1990) and Shirmann (1987). It modifies the procedure of Anderson and Hauck (1990) by imposing lognormal distribution assumption to better assess the individual bioequivalence. The corresponding equivalence limits for the individual and average bioequivalences are also presented.
    Relation: 行政院國家科學委員會
    計畫編號NSC84-2331-B004-001
    Data Type: report
    Appears in Collections:[統計學系] 國科會研究計畫

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML2688View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback